Previous close | 25.80 |
Open | 26.90 |
Bid | 26.50 |
Ask | 27.10 |
Strike | 220.00 |
Expiry date | 2024-12-20 |
Day's range | 26.90 - 27.20 |
Contract range | N/A |
Volume | |
Open interest | 115 |
It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...
Insulet stock was surging Tuesday after the healthcare company said its Omnipod 5 Insulin System got approval from the Food and Drug Administration. Insulet said in a news release Tuesday that its Omnipod 5 Automated Insulin Delivery System has been cleared by the FDA for use by people over 18 with Type 2 diabetes. The Omnipod 5 is an insulin delivery system that is used to manage blood sugar levels.
PODD marks a major milestone with Omnipod 5 approval for the treatment of type 2 diabetes.